Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
SARS- CoV-2, Cardiovascular Diseases, Chronic Kidney Diseases
About this trial
This is an interventional supportive care trial for SARS- CoV-2 focused on measuring health inequities, rural, Black/African American, dyads, structural determinants of health, quality of life
Eligibility Criteria
Inclusion Criteria:
COVID-19 survivor inclusion criteria
- African American
- Male and female
- Living in a Medically Underserved Area of South Carolina; rural
- ≥ 18 years and above
- A history of a COVID-19-associated hospitalization since March 11th 2020
A previous diagnosis of one or more of the following conditions: type 2 diabetes, hypertension, cardiovascular disease, chronic kidney disease, or stroke (>3 months)
-Carepartner inclusion criteria
- Male and female
- ≥ 18 years and above
- Must live on same property or community preferably within 20-mile radius as the survivor
- Primarily responsible for care provision/ care support in the home (i.e., is not paid for services)
Exclusion Criteria:
- Survivor and Carepartner exclusion criteria • Enrolled in related clinical trials
Sites / Locations
- University of South CarolinaRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
iCINGS Fam Intervention
Attention Control
Integrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM) is 14-week, nurse coordinated, Community Health Worker (CHW) supported telehealth intervention structure. After baseline assessment, dyads randomized to the intervention group (n= 125 dyads) will have two planning sessions (over 2 weeks) followed by eight topic-guided sessions delivered by a member of the RN-CHW team over 12 weeks (weekly the first 4 weeks, then bi-weekly), Follow up assessments will occur at month 4 and month 7.
After baseline assessment, dyads randomized to the attention control group (n= 125 dyads) will receive monthly (3 in total; 7-10 min each) scripted phone calls on focused on general health risks and health promotion. Monthly telephone calls will cover readily accessible evidence-based public health messaging from the Centers for Disease Control and Prevention (CDC) Your Health, NIH and other public health community facing websites related to COVID-19 mitigation such as risk reduction and prevention strategies including flu vaccines, asymptomatic spread, and contact tracing. Follow up assessments will occur at month 4 and month 7.